Don’t let the high cost of brand continuous-combined hormone therapy disrupt your menopausal care. We help eligible patients access Prempro (conjugated estrogens/medroxyprogesterone acetate) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
The Prempro Prescription Assistance Program is a manufacturer-sponsored initiative that provides Prempro at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for menopausal hormone therapy patients who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, gynecology/primary care coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$260 | Save ~$190/mo |
| CVS Pharmacy | ~$280 | Save ~$210/mo |
| Walmart | ~$220 | Save ~$150/mo |
| Costco | ~$210 | Save ~$140/mo |
Generic CE + MPA | ~$30 | Generic — lower |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Patient Assistance Program is free to apply for and provides Prempro at no medication cost if approved. Our $69.95/month service covers full advocacy. With generic conjugated estrogens and generic medroxyprogesterone widely available at low cost, generic alternatives are usually the cheaper path for most patients.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Prempro:
Still $200–$280 per month even with the best discount
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Prempro assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Prempro is a continuous-combined menopausal hormone therapy — both conjugated estrogens and medroxyprogesterone given daily in a single tablet. The continuous progestin protects the endometrium and typically eliminates scheduled withdrawal bleeding (after an adjustment period). It is used for women with an intact uterus who prefer no monthly bleeding.
How Prempro Works:
Postmenopausal estrogen deficiency causes symptoms like hot flashes and accelerated bone loss, which can be treated effectively with estrogen replacement therapy. Because estrogen alone stimulates endometrial growth, adding a progestin is necessary to protect the endometrium in women with an intact uterus. Prempro delivers both conjugated equine estrogens and medroxyprogesterone acetate daily for systemic replacement and endometrial protection. This continuous-combined regimen causes endometrial atrophy, which ultimately eliminates scheduled monthly bleeding after an initial adjustment period.
Form and use:
Prempro is taken orally as one tablet daily at the same time each day, and it is available in four different strength combinations of conjugated estrogens and medroxyprogesterone acetate. Clinical guidance recommends using the lowest effective dose that achieves adequate symptom control. While irregular spotting or bleeding is common during the first 3 to 6 months of therapy, most women eventually become bleeding-free. However, any irregular bleeding that persists beyond 6 months requires a medical evaluation to check for underlying endometrial pathology.
Generic availability:
As of 2026, there is no generic version of Prempro available in the U.S., though prescribing its two individual components separately as generics offers a substantially cheaper option. Alternative continuous-combined oral products include Activella, FemHRT, and Mimvey, the latter of which has a generic version that is often the most affordable option in its class. For patients seeking non-oral routes, transdermal options like the Climara Pro and CombiPatch patches are also available.
Warnings:
Prempro carries prominent boxed warnings detailing increased risks for cardiovascular diseases like stroke, myocardial infarction, deep vein thrombosis, and pulmonary embolism, alongside elevated risks for breast cancer and probable dementia. It also bears warnings for ovarian cancer, gallbladder disease, hypertriglyceridemia, hepatic impairment, and severe hypocalcemia. Additionally, the medication can potentially worsen pre-existing chronic conditions such as asthma, diabetes, epilepsy, migraines, and lupus. To appropriately manage these health risks, Prempro should be used at the lowest effective dose for the shortest necessary duration.
Brand Prempro costs approximately $200–$280 per 28-day pack. Generic conjugated estrogens plus generic medroxyprogesterone prescribed separately is much cheaper — typically $30–$60/month combined. Through AffordMyPrescriptions, qualifying patients receive Prempro at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Yes — your prescriber can prescribe generic conjugated estrogens and generic medroxyprogesterone separately, taken together once daily. This achieves the same regimen as Prempro at substantially lower cost. The trade-off is two prescriptions and two pills daily instead of one. Some women prefer the convenience of the combination tablet; others prefer the cost savings of separate generics. Discuss with your prescriber.
Both contain conjugated estrogens + medroxyprogesterone. Prempro is continuous combined — both hormones every day — typically no scheduled bleeding after an adjustment period. Premphase is sequential — CE alone for 14 days, then CE + MPA for 14 days — resulting in monthly withdrawal bleeding (similar to menses). Continuous-combined (Prempro) is usually preferred in women several years past menopause who don’t want monthly bleeding; sequential (Premphase) may be preferred in early postmenopause.
The WHI (2002) showed increased risks of breast cancer, MI, stroke, DVT/PE, and dementia in older postmenopausal women on continuous-combined CE/MPA. Risks varied by age, time
since menopause, and individual factors. Current understanding: for women under 60 within 10 years of menopause with bothersome vasomotor symptoms, benefits of MHT often outweigh risks. For older women or those further from menopause, risks may outweigh benefits. Use lowest effective dose for shortest duration. Discuss individual risk factors with your prescriber.
Irregular spotting/bleeding during the first 3–6 months is common as the endometrium adjusts to continuous-combined hormones. After 6 months, persistent bleeding requires evaluation — typically endometrial sampling/biopsy to rule out hyperplasia or cancer. Most evaluations are reassuring, but bleeding shouldn’t be ignored.
Maybe. Transdermal estrogen (patches like Climara Pro, CombiPatch, generic estradiol patches) avoids first-pass liver metabolism — potentially with lower VTE risk and less effect on triglycerides than oral estrogen. Particularly considered in women with elevated VTE risk, hypertriglyceridemia, or migraine. Discuss transdermal options with your prescriber if oral therapy has drawbacks for you.
If denied, we explore alternatives — switching to generic conjugated estrogens + medroxyprogesterone separately (much cheaper), generic continuous-combined MHT products (Mimvey, FemHRT generic), transdermal options, or non-hormonal alternatives for hot flashes (paroxetine/Brisdelle, venlafaxine, gabapentin, fezolinetant, elinzanetant — all generics except for the newer agents), the manufacturer’s copay program for commercially insured patients, or independent foundations. If we cannot find a path, you won’t be charged our service fee.
If you are struggling with the high cost of Prempro, our team may be able to help you access assistance programs — or guide you to generic alternatives. Check your eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.